Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2007
05/23/2007CN1965925A Externally applied Chinese medicine for treating dermatosis
05/23/2007CN1965914A Externally applied herbal medicine for treating virus infected herpes
05/23/2007CN1965907A Chinese medicinal spray for preventing and treating cold and method for preparing same
05/23/2007CN1965896A Prunella plant extract, preparation method, medical use and application thereof
05/23/2007CN1965895A Medicament for treating tuberculosis
05/23/2007CN1965883A Anti-hepatitis B compound formulation, preparation process and application thereof
05/23/2007CN1965877A Chinese medicinal eye drop for treating bacteria and virus infected conjunctivitis
05/23/2007CN1965857A Eye drop of povidone iodine and preparation process thereof
05/23/2007CN1965853A Application of gentiopicroside in preparation of antiviral medicament
05/23/2007CN1965851A Composition prepared by ambroxol and four kinds of antibacterials respectively
05/23/2007CN1965850A Roxithromycin injection and preparation process thereof
05/23/2007CN1965847A Amikacin solution containing clustered water used for animal
05/23/2007CN1965846A Neomycin sulphate solution containing clustered water used for animal
05/23/2007CN1965844A Nasal administered pharmaceutical composition containing glycyrrhetic acid and medical use thereof
05/23/2007CN1965838A Pharmaceutical composition containing cefpiramide and beta-lactamase inhibitor
05/23/2007CN1965837A Ofloxacin solution containing clustered water used for animal
05/23/2007CN1965835A Sarafloxacin hydrochloride solution containing clustered water used for animal
05/23/2007CN1965834A Enrofolxacn solution containing clustered water used for animal
05/23/2007CN1965833A 3CL protease inhibitor of non-peptide SARS coronavirus and use thereof
05/23/2007CN1965831A Application of yohimbine and berberine mixture in medicament preparation
05/23/2007CN1965828A Danofloxacin mesylate solution containing clustered water used for animal
05/23/2007CN1965827A Difloxacin hydrochloride solution containing clustered water used for animal
05/23/2007CN1965824A Pharmaceutical salt of ornidazole and L- ornidazole, preparation process and use thereof
05/23/2007CN1965816A Medicament for preventing and treating bacterial disease of domestic silkworm and preparation process thereof
05/23/2007CN1965812A Two kinds of tablet of cinnamyl aldehyde and preparation process thereof
05/23/2007CN1965804A Hydrogel suppository of berberine hydrochloride and preparation process thereof
05/23/2007CN1317301C Modulation of IL-2-and IL-15-mediated T cell responses
05/23/2007CN1317300C Glycine-riched protein and active fragment and use thereof
05/23/2007CN1317291C Oligonucleotide N3'-P5' thiophosphoramidates, their synthesis and use
05/23/2007CN1317278C Heterocyclic compounds and their use as medicines
05/23/2007CN1317277C Benzofuran derivatives and their use as antibacterial agents
05/23/2007CN1317010C Dripping pill for tonifying heart and kidney and its preparing method
05/23/2007CN1316999C Medicine for treating wind warmth and lung heat pathocondition and its preparation method
05/23/2007CN1316998C Powder for treating hepatitis B and liver cirrhosis
05/23/2007CN1316980C Medicinal use of spanish moss of Chinese traditional medicine
05/23/2007CN1316977C Stabilized brivudine topical formulations
05/23/2007CN1316973C Beta-carotene clathrate and its preparation method
05/23/2007CN1316968C Application of indole-2,3-diketone in preparing medication for antivirus or immunopotenfiator
05/22/2007US7220867 Dissolving with crystal growth inihibitos; drying
05/22/2007US7220856 Substituted quinoline CCR5 receptor antagonists
05/22/2007US7220771 Jun n-terminal kinase inhibitors
05/22/2007US7220769 Azolylbenzamides and analogues and their use for treating osteoporosis
05/22/2007US7220768 Prevention reproduction of herpes virus
05/22/2007US7220758 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors
05/22/2007US7220757 Topically administering to the patient an antibacterially effective amount compounds such as N-(4,5-Dibromothien-2-ylmethyl)-N'-(1H-imidazo[4,5-b]pyridine-2-yl)-propane-1,3-diamine for therapy of bacterial infection
05/22/2007US7220752 Liver selective glucocorticoid receptor antagonists; lowering blood glucose levels; 3,5-dibromo-4-(5-isopropyl-2-(3-methylbenzoyl)-4-(3-methyl-3-b utenyloxy)phenoxy)-phenylacetic acid for example
05/22/2007US7220745 Viricides; therapy for hepatitis virus infections
05/22/2007US7220739 Therapeutic application of pro-apoptotic benzodiazepines
05/22/2007US7220738 Rifamycin analogs and uses thereof
05/22/2007US7220726 Antifungal pimaricin compositions and therapeutic methods employing same
05/22/2007US7220719 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening
05/22/2007US7220559 Development of human monoclonal antibodies and uses thereof
05/22/2007US7220551 Vaccine containing human papillomarus virus antigen, aluminum hydroxide and a preferential stimulator of TH1 cell response such as 3 De-O-acylated monophosphoryl lipid A (3D-MPL)
05/22/2007US7220545 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method
05/22/2007US7220420 Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses
05/22/2007US7220419 Self-assembling recombinant papillomavirus capsid proteins
05/22/2007CA2276694C New fatty acid derivatives
05/22/2007CA2217882C European vaccine strains of the porcine reproductive and respiratory syndrome virus (prrsv)
05/22/2007CA2208436C Unitary vaginal dosage form useful as a local contraceptive and/or for combatting sexually transmitted diseases and/or hiv
05/22/2007CA2206296C Low rigidity liposomal antibacterial composition
05/22/2007CA2182274C Antigenic preparation for treatment or prevention of helicobacter infection
05/22/2007CA2143187C Anti-feline immunodeficiency virus (fiv) vaccines
05/22/2007CA2119236C Use of ifn-gamma for the treatment of infections in transplant recipients
05/22/2007CA2110518C Ctla4 receptor, fusion proteins containing it and uses thereof
05/18/2007WO2007056330A1 Benzimidazole derivatives as gyrase inhibitors
05/18/2007WO2007056195A2 Surfactant protein-d for prevention and treatment of lung infections and sepsis
05/18/2007WO2007056120A1 Hepatitis c virus inhibitors
05/18/2007WO2007055578A1 Cyclic antimicrobial peptides derived from lactoferrin
05/18/2007WO2007055260A1 Material for detection or quantification of human immunodeficiency virus-1 gene, detection or quantification method, gene fragment for therapy, and therapeutic method
05/18/2007WO2007055183A1 Benzene derivative or salt thereof
05/18/2007WO2007054814A1 Inhibitors of parp activity and uses thereof
05/18/2007WO2007054741A1 Tetracyclic indole derivatives as antiviral agents
05/18/2007WO2007054296A1 Macrolones
05/18/2007WO2007054085A2 Antiviral agent comprising tribomechanically activated zeolite (tmaz), propolis, and colostrum
05/18/2007WO2007054030A1 Polyethylene glycol modifications of thymosin alpha-1
05/18/2007WO2007053982A1 Chinese pharmaceutical compositions for treating epidemic cerebrospinal meningitis and processes for preparation thereof
05/18/2007WO2007053874A1 Use of propolis for producing a medicament
05/18/2007WO2007031334A3 Vaccines comprising truncated hbc core protein plus saponin-based adjuvants
05/18/2007WO2007025089A3 Triazole compounds and methods of making and using the same
05/18/2007WO2007018622A3 Vaginal treatment composition
05/18/2007WO2007014934A8 Quinoline derivatives as antibacterial agents
05/18/2007WO2007007086A3 Antibodies for anthrax
05/18/2007WO2007006544A3 Cyclic adenosine monophosphate compounds for the treatment of immune-related disorders
05/18/2007WO2006131749A3 Scaffold
05/18/2007WO2006119395A3 Combination of a beta-glucan and an egf receptor antagonist for the treatment of cancer and infection
05/18/2007WO2006118948A3 Therapeutic compositions
05/18/2007CA2629376A1 Inhibitors of parp activity and uses thereof
05/18/2007CA2628937A1 Tetracyclic indole derivatives as antiviral agents
05/18/2007CA2628472A1 Surfactant protein-d for prevention and treatment of lung infections and sepsis
05/18/2007CA2628113A1 Peptide-dicer substrate rna conjugates as delivery vehicles for sirna
05/18/2007CA2626685A1 Benzimidazole derivatives as gyrase inhibitors
05/18/2007CA2624905A1 Pqs and its conjugates as adjuvants and their uses in pharmaceutical compositions
05/18/2007CA2624903A1 Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions
05/18/2007CA2610662A1 Foamable vehicle and pharmaceutical compositions thereof
05/17/2007US20070112205 Cyanopyrrolidine derivatives
05/17/2007US20070112059 Cyanopyrrolidine derivatives
05/17/2007US20070112046 2'-Methyl-5'-(1,3,4-Oxadiazol-2-yl)-1,1'-Biphenyl-4-Carboxamide Derivatives and Their Use As P38 Kinase Inhibitors
05/17/2007US20070112022 Piperidine derivatives as ccr5 receptor modulators
05/17/2007US20070112014 Therapeutic Compounds Based on Pyrazolopyridine
05/17/2007US20070112013 Method of modulating ion channel functional activity